How to Evaluate a Private-Company Valuation
Understanding the Direct Deal
Evaluating whether a private company's valuation is reasonable means comparing it against relevant reference points, since there is no public market price to anchor against — the specific comparables and methodology used matter as much as the resulting number itself.
Reading Rights, Price and Lead-Investor Quality
Useful reference points include: revenue or growth multiples of genuinely comparable listed or recently funded private companies in the same sector and stage; the trajectory of the company's own prior round valuations and whether growth in valuation has tracked growth in fundamentals; and whether the round is being priced by a credible, arm's-length lead investor or set unilaterally by the company.
Where Deal Underwriting Breaks
The common failure is anchoring only to the company's narrative about its own potential without checking it against actual comparable multiples. A compelling growth story can still be priced well above what genuinely comparable companies command, especially in periods of high investor enthusiasm for a particular sector.
Making the Investment Decision
Before committing, independently identify 3-5 genuinely comparable companies (similar sector, stage, growth rate) and their most recent valuation multiples, compare the round's implied multiple against them, and understand whether a credible arm's-length lead investor set this specific price or the company set it unilaterally.
A private-company valuation is only meaningful in comparison to genuine peers — never accept a valuation based solely on the company's own narrative about its potential.
Key takeaways
- Private-company valuation requires comparison against relevant reference points — there's no public price to anchor to.
- Compare revenue or growth multiples against genuinely comparable companies in the same sector and stage.
- A compelling growth narrative can still be priced well above what real peers actually command.
- Check whether a credible arm's-length lead investor set the price, or the company set it unilaterally.
More in Co-Investments and Direct Private Deals
Continue with the other chapters in this module.
Related questions
What should an investor verify first?
The valuation multiples of 3-5 genuinely comparable companies in the same sector and growth stage.
Which documents matter most?
The company's prior round valuation history, to see whether growth has tracked fundamentals.
What is the main downside to test?
Anchoring to the company's own growth narrative without checking it against real comparable multiples.
How should the final decision be made?
Confirm whether a credible arm's-length lead investor set the price, or the company set it unilaterally.
Need personalized advice?
Schedule a conversation about your private market allocation goals.
Request an advisory call